CLINICAL_TRIALS
trial_result
· 2019-04-22
Clinical Trial Update: Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants [Phase 4]
Summary
Phase 4 clinical trial update for the XEN implant in moderate primary open angle glaucoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AqueSys, Inc. | Conditions: Primary Open Angle Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2019-04-22